SLC5A2 and diabetes mellitus: Furthermore, a longitudinal study found a link between long-term (3+ years) SGLT2 inhibitor use on geriatric diabetics and improved cognitive function, as was measured by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) [167].